Human Microbiome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Devices, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorder

Human Microbiome Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Devices, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography

The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027.

The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. On the other hand, strict government guidelines and lack of knowledge and detailed examination are likely to have a negative impact on the growth of the market in the coming years.

Humans usually coexist with the diverse microbial species living within and over humans. Various recent scientific studies have proven that the microbial community essentially acts like an organ of the body that plays a crucial role in human disease management and physiology. Various basic and translational research efforts have been initiated that focuses on deciphering mechanisms of the microbiome function and the ways that it benefits the human health. Various human medical conditions such as inflammatory bowel diseases and obesity have been closely associated with and are thought to be influenced by the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements, and foods that contain live microbes have been studied thoroughly to assess their effects on human health.

The Human Microbiome Project of the National Institutes of Health in the US and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to diseases. Large governmental research initiatives including the Human Microbiome Project in the U.S. and the MetaHIT Project in Europe have accelerated research on the human microbiome.

Based on product, the human microbiome market is segmented into probiotics, foods, prebiotics, medical foods, diagnostic devices, drugs, and supplements. In 2019, the probiotics segment held the largest share of 24.73% of the human microbiome market, by product. This segment is also expected to dominate the market in 2027 owing to increasing health concerns; growing awareness regarding the relation of nutrition, diet, and health; and increasing probiotics market penetration in dairy and other foods. Furthermore, the prebiotics segment is anticipated to witness the fastest growth rate during the forecast period.

Several players have observed good demand for human microbiome based products during the initial period of COVID-19, particularly from the food & beverages industry. In addition, researchers are studying the correlation between gut bacteria and COVID-19. Many researchers have showcased gut bacteria's implication in different health conditions, from type 2 diabetes to depression. However, the obstacles in supply chains and distribution networks resulting in unavailability of human microbiome based products in various parts of the world are likely to hamper the growth of the market in 2020.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union, Organization for Economic Co-operation and Development, Canadian Institute for Advanced Research, Biotechnology Industry Research Assistance Council and American Cancer Society (ACS) are a few of the essential secondary sources referred to while preparing this report.

Reason to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Microbiome Market – By Product
1.3.2 Global Human Microbiome Market – by Disease
1.3.3 Global Human Microbiome Market – by Application
1.3.4 Global Human Microbiome Market – By Geography
2. Human Microbiome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Human Microbiome Market – Market Landscape
4.1 Overview
4.1.1 North America – PEST Analysis
4.1.2 Europe– PEST Analysis
4.1.3 Asia Pacific– PEST Analysis
4.1.4 Middle East And Africa– PEST Analysis
4.1.5 South and Central America – PEST Analysis
4.2 Expert Opinions
5. Human Microbiome Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidence of Lifestyle Diseases
5.1.2 Increasing Focus On Human Microbiome Therapies
5.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
5.2 Key Market Restraints
5.2.1 Strict Government Guidelines
5.2.2 Lack of Knowledge and Detailed Examination
5.3 Key Market Opportunities
5.3.1 New Drug Requirements for Faecal Microbiota
5.3.2 Emerging Nations
5.4 Future Trends
5.4.1 The Human Microbiome - A New Frontier in Drug Discovery
5.5 Impact analysis
6. Human Microbiome Market – Global Analysis
6.1 Global Human Microbiome Market Revenue Forecast and Analysis
6.2 Global Human Microbiome Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Human Microbiome Market Analysis – By Product
7.1 Overview
7.2 Human Microbiome Market Revenue Share, by Product (2019 and 2027)
7.3 Foods
7.3.1 Overview
7.3.2 Foods: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Medical Food
7.4.1 Overview
7.4.2 Medical Food: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Probiotics
7.5.1 Overview
7.5.2 Probiotics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Drugs
7.6.1 Overview
7.6.2 Drugs: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Diagnostic Devices
7.7.1 Overview
7.7.2 Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Supplements
7.8.1 Overview
7.8.2 Supplements: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
8. Human Microbiome Market Analysis – By Disease
8.1 Overview
8.2 Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
8.3 Diabetes
8.3.1 Overview
8.3.2 Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cancer
8.4.1 Overview
8.4.2 Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Autoimmune Disorders
8.5.1 Overview
8.5.2 Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Obesity
8.6.1 Overview
8.6.2 Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Mental Disorders
8.7.1 Overview
8.7.2 Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others Market
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Human Microbiome Market Analysis – By Application
9.1 Overview
9.2 Human Microbiome Market Revenue Share, by Application(2019 and 2027)
9.3 Diagnostics
9.3.1 Overview
9.3.2 Diagnostics:Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics:Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
10. Human Microbiome Market Analysis and Forecasts To 2027 Geographical Analysis
10.1 North America: Human Microbiome Market
10.1.1 Overview
10.1.2 North America: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.5 North America: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.6 North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.1.7 US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.7.4 US: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.8 Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.8.4 Canada: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.1.9 Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.1.9.4 Mexico: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.2 Europe: Human Microbiome Market
10.2.1 Overview
10.2.2 Europe: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UKHuman Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK: Human Microbiome Market, Usability – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Human Microbiome Market
10.3.1 Overview
10.3.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.4 Asia Pacific: Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.6 Asia Pacific: Human Microbiome Market, by Country, 2018 & 2027 (%)
10.3.7 China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.7.3 ChinaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.7.4 China Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.8 Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.8.3 JapanHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.8.4 JapanHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.9 India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.9.3 IndiaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.9.4 IndiaHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.10 South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.10.3 South KoreaHuman Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.10.4 South KoreaHuman Microbiome Market, by Application, 2018–2027 (USD Million)
10.3.11 Australia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Human Microbiome Market, by Product, 2018–2027 (USD Million)
10.3.11.4 Australia Human Microbiome Market, by Disease, 2018–2027 (USD Million)
10.3.11.5 Australia Human Microbiome Market, by Application, 2018–2027 (USD Million)
10.4 Middle East & Africa: Human Microbiome Market
10.4.1 Overview
10.4.2 Middle East & Africa: Human Microbiome Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.6 Middle East & Africa: Human Microbiome Market, by Country, 2019& 2027 (%)
10.4.6.1 Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.6.2 Saudi Arabia: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.6.3 Saudi Arabia Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.6.4 Saudi Arabia Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.6.5 Saudi Arabia Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.7 UAE: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 UAE: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 UAE Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.7.3 UAE Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.7.4 UAE Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.4.8 South Africa: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 South Africa: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 South Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.4.8.3 South Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.4.8.4 South Africa Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.5 South and Central America: Human Microbiome Market
10.5.1 Overview
10.5.2 South and Central America: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Human Microbiome Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
10.5.8 Argentina: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Human Microbiome Market, by Application– Revenue and Forecast to 2027(USD Million)
11. Impact of COVID-19 Pandemic on Global Human Microbiome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Human Microbiome Market – Industry Landscape
12.1 Growth Strategies in the Human Microbiome Market, 2015-2020
12.2 Organic Growth Strategies
12.2.1 Overview
12.2.2 Product Launch & Approvals
12.2.3 Expansion
12.2.4 Patent and license
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.3.2 Acquisitions
12.3.3 Partnerships, Collaborations & Agreements
12.3.4 Joint Ventures
13. Company Profiles
13.1 ENTEROME
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Rebiotix Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Yakult Honsha Co., Ltd.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Osel Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 Swot Analysis
13.4.6 Key Developments
13.5 Vedanta Biosciences, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Information
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Synthetic Biologics, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Information
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 DuPont
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BiomX
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Information
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 MaaT Pharma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ELIGO BIOSCIENCE
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 AOBiome
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Kaleido Biosciences, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Seres Therapeutics
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Merck & Co., Inc.
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. US Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. US Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 6. US Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. United Kingdom Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million).
Table 21. UK: Human Microbiome Market, Usability – Revenue and Forecast to 2027 (USD Million)
Table 22. France Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 23. France Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 24. France Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 31. Asia Pacific Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 34. China Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 35. China Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 36. China Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 37. Japan Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 40. India Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 41. India Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 42. India Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 43. South Korea Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 46. Australia Human Microbiome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 49. Middle East & Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Human Microbiome Market, by Application – Revenue and Forecast to 2027(USD Million)
Table 52. Saudi Arabia Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 55. UAE Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 58. South Africa Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 61. South and Central America Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 67. Argentina Human Microbiome Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Human Microbiome Market, by Disease – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Human Microbiome Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 70. Recent Product Launches & Approvals in the Human Microbiome Market
Table 71. RecentEXPANSIONS in the Human Microbiome Market
Table 72. Patent and License Organic Growth Strategies in the Human Microbiome Market
Table 73. Recent Acquisitions in the Human Microbiome market
Table 74. Recent Partnerships & Collaborations in the Human Microbiome market
Table 75. Joint Ventures inOrganic Growth Strategies in the Human Microbiome Market
Table 76. Glossary of Terms, Human Microbiome Market
LIST OF FIGURES
Figure 1. Human Microbiome Market Segmentation
Figure 2. Human Microbiome Market Segmentation, By Region
Figure 3. Human Microbiome Market Overview
Figure 4. Probiotics Segment Held Largest Share of Human Microbiome Market
Figure 5. Asia-Pacific to Show Significant Growth During Forecast Period
Figure 6. Human Microbiome Market, by Geography (US$ Million)
Figure 7. Global Human Microbiome Market – Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Asia pacific PEST Analysis
Figure 11. Middle East and Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Human Microbiome Market Impact Analysis of Driver and Restraints
Figure 14. Global Human Microbiome Market – Revenue Forecast And Analysis – 2019- 2027
Figure 15. Global Human Microbiome Market – By Geography Forecast and Analysis – 2019- 2027
Figure 16. Market Positioning Of Key Players In Global Human Microbiome Market
Figure 17. Human Microbiome Market Revenue Share, by Product (2019 and 2027)
Figure 18. Foods: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Medical Food: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Probiotics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Drugs: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Supplements: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Human Microbiome Market Revenue Share, by Disease(2019 and 2027)
Figure 25. Global Diabetes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Autoimmune Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Obesity Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Mental Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Human Microbiome Market Revenue Share, by Application(2019 and 2027)
Figure 32. Diagnostics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Therapeutics: Human Microbiome Market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. North America: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. North America Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 36. North America: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 37. US: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Canada: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Mexico: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Europe: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 41. Europe Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 42. Europe: Human Microbiome Market, by Country, 2019 & 2027 (%)
Figure 43. Germany: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. UK: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. France: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Spain: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Italy: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia Pacific: Human Microbiome Market, by Key Country – Revenue (2019) (USD Million)
Figure 49. Asia Pacific Human Microbiome Market Revenue and Forecast to 2027 (USD Million)
Figure 50. China: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. India: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Human Microbiome Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Austr

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook